FDBusiness.com

GELITA, the world’s leading manufacturer of collagenous proteins, returns to Vitafoods Europe (Geneva, Switzerland, 10–12 May) to showcase the latest science in Bioactive Collagen Peptide® supplementation. Being the official collagen peptide sponsor of the show and a market-leading contributor to clinical collagen peptide research, the company will highlight its latest findings in the areas of sarcopenia and cellulite treatment during the exhibition. Moreover, GELITA will present the future of soft capsule production with reduced cross-linking characteristics.

Muscle strength and body toning

As societies age and global demographics change, sarcopenia has evolved into a serious health problem. To fight the age-related loss of muscle mass and strength, GELITA has developed specific Bioactive Collagen Peptides® named BODYBALANCETM. A recently published clinical study demonstrated that a combination of resistance exercise and BODYBALANCETM supplementation offers a viable approach to fight and prevent sarcopenia in the elderly. A new just finished study was investigating the effects of BODYBALANCETM intake on body toning and muscle strength in young adults. The initial results are very promising and will be a topic for debate at the GELITA booth.

Cellulite treatment

The positive impact of VERISOL® on skin health is well documented in various clinical trials. Now, a new study shows that these specific collagen peptides also help to restore the normal structure of the dermal and subcutaneous tissue in cellulite-affected body parts. By tackling the causes as opposed to the symptoms, VERISOL® collagen peptides pave the way for a new therapeutic strategy to treat cellulite. Nutritional experts will be on stand to discuss the growing opportunities for collagen peptide supplementation in beauty- and health-related applications.

Advanced capsule technology

To further increase the application range of soft gelatine capsules, GELITA highlights GELITA® RXL ADVANCED at this year’s Vitafoods. Providing decreased cross-linking and reduced drying times, the pharmaceutical gelatine guarantees reliable fill release and more efficient capsule production. Protected by US and other international patents, this gelatine grade improves dissolution and capsule shelf-life and provides significant benefits for the development of OTC products with faster fill release characteristics, even at high humidity and very warm temperatures.

Experts on stage

GELITA’s leadership in the field of collagenous proteins is reflected in the official Vitafoods programme, which will feature two presentations from GELITA experts:

• Wednesday, 11 May, 2.35 pm: Dr Holger Beck, Technical Product Manager Pharma at GELITA, will discuss GELITA® RXL Gelatine and its potential for reduced cross-linking, increased fill release performance and improved shelf-life at the Exhibitor Presentation Theatre.
• Wednesday, 11 May, 4.15 pm: Experience how supplementation with BODYBALANCE™ Bioactive Collagen Peptides® counteracts the onset of sarcopenia at the interactive hour on the Vitafoods Central Stage.

GELITA is the leading company for manufacturing and marketing collagen proteins. Coordinated from the headquarters in Eberbach, Germany, GELITA provides customers around the world with products of the highest standard, comprehensive technical expertise and sophisticated solutions. More than 20 sites and a global expert network ensure that state-of-the-art know-how is always available for customers.